ShadiaIJalalMD

Clinical Trials

• Study of RAD001 + AMG479 for Patients With Advanced Solid Tumors Start of enrollment: 2010 May 14

  Completed

  Phase 1

• Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer Start of enrollment: 2010 Sep 21

  Active, not recruiting

  Phase 2

• Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer Start of enrollment: 2012 Sep 28

  Completed

  Phase 1, Phase 2

• Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer Start of enrollment: 2013 Feb 01

  Terminated

  Phase 2, Phase 3

• LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib Start of enrollment: 2013 Jun 28

  Completed

  Phase 3

• Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Jul 08

  Completed

• Circulating Tumor Cells (CTC) in Lung Cancer Start of enrollment: 2017 Oct 19

  Recruiting

• A Study of Durvalumab (MEDI4736) in Esophageal Cancer Start of enrollment: 2016 Apr 27

  Completed

  Phase 2

• Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01

  Completed

  Phase 2

• Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01

  Completed

  Phase 2, Phase 3

• Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29

  Active, not recruiting

  Phase 3

• Fasting-mimicking Diet With Chemo-immunotherapy in Non-small Cell Lung Cancer (NSCLC) Start of enrollment: 2018 Nov 02

  Completed

  Not Applicable

• A Study Evaluating Safety and Efficacy of Niraparib in Patients With Previously Treated Metastatic Esophageal/Gastroesophageal Junction/Proximal Gastric Adenocarcinoma Start of enrollment: 2019 Jul 09

  Terminated

  Phase 2

• Guadecitabine in Combination With Carboplatin in Extensive Stage Small Cell Lung Cancer Start of enrollment: 2019 Jun 06

  Completed

  Phase 2

• Beyond the Lung Cancer Diagnosis: Leveraging the Oncology Clinic Setting for Actively Smoking Family Members Start of enrollment: 2021 Sep 13

  Terminated

• ADP-A2M4CD8 in HLA-A2+ Subjects With MAGE-A4 Positive Esophageal or Esophagogastric Junction Cancers (SURPASS-2) Start of enrollment: 2021 Sep 15

  Terminated

  Phase 2

  Roles: Principal Investigator, Contact

• Join now to see all